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Abstract
Innate immune recognition is based on the detection, by pattern recognition receptors (PRRs), of molecular structures that
are unique to microorganisms. Lipoglycans are macromolecules specific to the cell envelope of mycobacteria and related
genera. They have been described to be ligands, as purified molecules, of several PRRs, including the C-type lectins
Mannose Receptor and DC-SIGN, as well as TLR2. However, whether they are really sensed by these receptors in the context
of a bacterium infection remains unclear. To address this question, we used the model organism Mycobacterium smegmatis
to generate mutants altered for the production of lipoglycans. Since their biosynthesis cannot be fully abrogated, we
manipulated the biosynthesis pathway of GDP-Mannose to obtain some strains with either augmented (,1.7 fold) or
reduced (,2 fold) production of lipoglycans. Interestingly, infection experiments demonstrated a direct correlation between
the amount of lipoglycans in the bacterial cell envelope on one hand and the magnitude of innate immune signaling in
TLR2 reporter cells, monocyte/macrophage THP-1 cell line and human dendritic cells, as revealed by NF-kB activation and IL-
8 production, on the other hand. These data establish that lipoglycans are bona fide Microbe-Associated Molecular Patterns
contributing to innate immune detection of mycobacteria, via TLR2 among other PRRs.
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Introduction
Innate immune recognition is based on the detection of
molecular structures that are unique to microorganisms [1]. It
involves a limited number of germline-encoded pattern recogni-
tion receptors (PRRs) that recognize conserved molecules of
microbes, referred to as microbe-associated molecular patterns
(MAMPs) [2]. MAMPs follow three criteria: i) they have an
invariant core structure among a given class of microorganisms, ii)
they are products of pathways that are unique to microorganisms
and iii) they are essential for the survival of the microorganism and
are therefore difficult for it to alter [1]. Most of them have been
characterized by their capacity, as purified molecules, to bind
PRRs and/or to activate PRR-mediated signaling. However,
whether they really contribute to microbe recognition by innate
immune system in a physiological context is not always clearly
demonstrated and remains for some of them under debate [3].
The most controversial situation is probably that observed for
TLR2 ligands. Indeed, of all TLRs, TLR2 is the receptor that
recognizes the structurallybroadestrange ofMAMPs[3].Itsligands
are as diverse as lipoproteins, lipopeptides, lipoteichoic acid (LTA),
peptidoglycan, zymosan, GPI anchors or lipoglycans [3]. This high
diversityinligandrecognitionhasbeenproposedtopossiblyarise,at
least in part, from its capacity to function as a heterodimer with
either TLR1 or TLR6 [4]. However, because some of these
molecules are structurally unrelated, their real nature as TLR2
ligands is a matter of controversy [3]. Indeed, no obvious structure-
function relationship can be drawn as one could expect from an
ordinary receptor-ligand interaction [5]. This chaotic situation
results from both the use of incompletely defined agonist
preparations and the lack, until very recently, of high resolution
structuraldatadefiningtheseinteractionsattheatomiclevel[3].For
example, the TLR2 activity originally found in some commercially
available LPS preparations was subsequently demonstrated to arise
from endogenous contaminating lipoproteins [6,7]. A similar
explanation is advanced for the observed TLR2 activity in
peptidoglycan fractions [3]. This assumption is reinforced by the
recently published crystal structure of a TLR1-TLR2 heterodimer
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clearly shows the importance of ligand acyl chains to bind and
induce heterodimerization of the receptors and provides a
rationale to tentatively understand the ligand structure-function
relationships, although the presence of binding sites other than
that of lipopeptides cannot be excluded [9,10]. For instance,
LTA, that bears two acyl chains, has been unambiguously
proved, using chemically synthesized analogs, to stimulate TLR2
[11] and recently demonstrated to bind TLR2 [12]. However, its
role as a physiological TLR2 ligand is still under debate
[3,13,14]. Indeed, a set of studies focusing on Staphylococcus aureus
and using cell wall-derived compounds as well as a mutant
lacking acylated lipoproteins, demonstrates that LTA is much less
active than lipoproteins and suggests that not LTA but
lipoproteins are the dominant immunobiologically active com-
pounds in this Gram-positive bacterium [3,13]. As a conse-
quence, in a recent review, Za ¨hringer et al [3] propose that
lipoproteins/lipopeptides are the only compounds of microor-
ganisms sensed at physiological concentrations by TLR2.
Lipoglycans are surface-exposed molecules of mycobacteria
[15,16,17] that have been described by other and us to be ligands,
as purified molecules, of several PRRs, including the C-type lectins
Mannose Receptor and DC-SIGN, as well as TLR2 (For a recent
review, see [18]). However, their real nature as MAMPs has never
been validated by isogenic mycobacterial mutants in the context of
a bacterium infection. Their structure is based on a mannosyl-
phosphatidyl-myo-inositol anchor, which, although very similar to
the GPI anchors found in eukaryotic cells, is specific of these
microorganisms [18]. The biosynthesis of the mannosyl-phospha-
tidyl-myo-inositol anchor is essential in mycobacteria [18,19]. The
most active lipoglycan, lipomannan (LM), is sensed by TLR2 at
concentrations similar to that of mycobacterial lipoproteins and we
have shown recently that it can compete for lipopeptide binding to
the receptor, suggesting that it shares at least in part the same
binding site [20]. Assuming that it is the case, straightforward
structure-function relationships can account for the observed
TLR2-stimulatory capacity of the various purified LM acyl-forms
[20,21]. Nevertheless, a contamination of lipoglycan fractions by
highly active lipopeptides is formally difficult to rule out.
Moreover, a Mycobacterium tuberculosis mutant deficient for lipopro-
tein processing is dramatically altered in its capacity to stimulate
TLR2 [22], suggesting, as for S. aureus, a predominant role of
lipoproteins in mycobacteria sensing by TLR2.
In order to determine whether lipoglycans are i) bona fide
MAMPs and most particularly TLR2 ligands and ii) sensed at
physiological concentrations in the context of the whole bacteri-
um, we used here the model organism Mycobacterium smegmatis to
generate mutants altered for the production of lipoglycans. Since
their biosynthesis cannot be fully abrogated [19], we attempted to
construct some strains with either an increased or a reduced
production of lipoglycans and we compared their ability to induce
innate immune signaling relatively to control strains in reporter
cells, macrophage cell line or dendritic cells. Finally, to compare
the relative contribution of lipoglycans and lipoproteins in
mycobacteria sensing by TLR2, we constructed a mutant deficient
for lipoprotein processing.
Materials and Methods
Construction of the M. smegmatis recombinant strains
Rv3255c (manA), Rv3257c (manB), Rv3308 (pmmB) and Rv3264c
(manC) genes were amplified from M. tuberculosis H37Rv genomic
DNA (TB Vaccine Testing and Research Materials Contract,
NIH, NIAID NO1-AI-40091) using the primers described in
Figure S1. The resulting PCR products were purified and digested
with HindIII on one hand and EcoRV (Rv3255c and Rv3264c), Bal
I( Rv3257c) and SmaI for (Rv3308) on the other hand. Restricted
PCR products were ligated into the BalI and HindIII-digested
pMV261 E. coli-mycobacteria shuttle vector [23], giving rise to the
pMVmanA, pMVmanC, pMVmanB and pMVpmmB. These plas-
mids were transferred into M. smegmatis mc
2155 by electroporation.
The strains were grown at 37uC in Middlebrook 7H9 medium
(Difco) supplemented with 40 mg/ml Kanamycin (Km).
Construction of the pmmB- and lspA-disrupted mutants
of M. smegmatis
A DNA fragment overlapping the pmmB gene (MSMEG_1695)
was amplified by PCR from M. smegmatis mc
2155 genomic DNA
using primers FP and RP (Figure S1). This PCR fragment was
cloned after insertion of a Km resistance gene surrounded by two
res sites from transposon cd (res-km-res cassette) between the EcoRI
and NcoI restriction sites, into the suicide plasmid pJQ200
[24,25]. This plasmid was electrotransferred into M. smegmatis and
the transformants were selected on plates containing Km (40 mg/
ml) and 5% sucrose. PCR screening for disruption of pmmB was
performed with a set of specific primers (FBP, RPB, RPI, res1 and
res2, Figure S1) after extraction of the genomic DNA from several
Km- and sucrose resistant colonies. One clone giving the
corresponding pattern for disruption of pmmB was selected for
further analyses and named Msmeg/DpmmB.
To construct the lspA-disrupted mutant of M. smegmatis,a
1700 bp DNA fragment containing the lspA gene (MSMEG_3174)
of M. smegmatis mc
2155 was amplified by PCR from genomic DNA
using oligonucleotides 3181A and 3181B (Figure S1). The PCR
product was digested with NotI and cloned, after insertion of the
res-km-res cassette at the NcoI restriction site, into the mycobac-
terial thermosensitive plasmid pCG217 which contains the
counterselectable marker sacB and the xylE reporter gene. The
resulting vector was electrotransformed in M. smegmatis mc
2155,
and transformants were selected on 7H11 agar plates containing
Km (40 mg/ml) at 32uC. Few clones were selected and grown in
5 mL of 7H9 medium containing Km at 32uC for 3 days. Several
dilutions of these cultures were then plated onto 7H11 agar plates
containing Km, catechol and 2% sucrose, and incubated at a non-
permissive temperature (42uC). PCR screening for disruption of
lspA was performed with a set of specific primers (3181C, 3181D,
res1b, res2b, kan1, kan2) (Figure S1) after extraction of the
genomic DNA from several Km- and sucrose-resistant colonies.
One clone giving the corresponding pattern for disruption of lspA
was selected for further analyses and named Msmeg/DlspA.
To generate a lspA mutated strain carrying no antibiotic
resistant marker, the Msmeg/DlspA mutant was transformed with
the thermosensitive plasmid pWM19, which contains the
resolvase gene of transposon cd and an hygromycin (Hyg)
resistance gene [24]. Transformants were resuspended in 5 ml of
7H9 medium and incubated for 6 h at 32uC to allow the
expression of Hyg resistance. Hyg (100 mg/ml) was then added to
the transformation mixture, and cells were incubated for 24 h at
32uC. Serial dilutions of the bacterial culture were then plated on
7H11 plates and incubated at 42uC. Several colonies were picked
and tested for growth on plates containing Km. Two clones that
were unable to grow on Km-containing plates but that showed
normal growth on control antibiotic-free plates were selected and
analyzed by PCR using primers 3181C and 3181D. One clone
giving the corresponding pattern for excision of the Km
resistance cassette in lspA was retained for further analysis and
named Msmeg/DlspAres.
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Complementation plasmids pMV/MSMEG_1695 and pMV/
MSMEG_3174 were constructed by amplifying pmmB and lspA
from M. smegmatis mc
2155 genomic DNA using primers PMFP and
PMRP and primers 3181I and 3181J respectively (Figure S1). The
PCR products were digested with NdeI and HindIII and cloned
between the NdeI and HindIII sites of pMV361eHyg, a pMV361
derivative containing the pblaF* promoter instead of the original
phsp60 promoter and carrying a hyg resistance marker [23]. pMV/
MSMEG_1695 was transferred into the Msmeg/DpmmB mutant
strain and pMV/MSMEG_3174 was transferred into the Msmeg/
DlspA and Msmeg/DlspAres mutants. Transformants were selected
on 7H11 agar plates supplemented with Hyg (50 mg/ml) and Km
(40 mg/ml) when necessary.
Expression of recombinant protein Msmeg1712-HA
The vector pHSG84 encoding the endogenous lipoprotein
Msmeg1712-hemagglutinin (HA) tagged was graciously provided
by Miriam Braunstein (University of North Carolina at Chapel
Hill). Msmeg1712-HA was expressed from the native
MSMEG_1712 promoter. The plasmid pHSG84, carrying a Km
resistance gene, was electrotransformed in Msmeg/DlspAres strain
and its complemented counterpart. The transformants were
selected on 7H11 agar plates containing kanamycin (40 mg/ml).
Few clones were selected for Msmeg1712-HA expression analysis
by western blot.
Enzymatic assays
Recombinant strains were grown in the presence of 0.05%
Tween 80 until OD at 600 nm reached 1.0, harvested by
centrifugation, washed with PBS and disrupted by sonication.
Cell lysates were centrifuged at 4uC for 30 min at 27000 g and the
supernatants were used for enzyme assays. Protein concentration
was determined using the Bio-Rad protein assay. Enzymatic
activities were determined at 37uC in 1 ml reaction volume (4 mg
of proteins) by monitoring the reduction of NADP to NADPH at
340 nm, using coupled enzyme reactions as previously described
[26,27,28].
Carbohydrate quantification and lipoglycan analysis by
SDS-PAGE
Enriched lipoglycan fractions containing glycans and proteins
were prepared as previously described [15]. Briefly, mycobacterial
cells were delipidated by several extractions with CHCl3/CH3OH
(1:1, v/v), yielding a lipidic extract containing PIM. Delipidated
cells were then disrupted by sonication. Lipoglycans, LM and
LAM, were further extracted by refluxing the broken cells in 50%
ethanol at 65uC. Contaminating nucleic acids and glucans were
removed by enzymatic degradation treatments followed by
dialysis. Proteins were degraded by protease digestion to avoid
their superimposition with lipoglycans on the SDS-PAGE gel but
were not removed from the fractions to keep them as an internal
reference between the different strains. Arabinose and mannose
were quantified from an equivalent amount of 1 mg of proteins by
capillary electrophoresis after total acid hydrolysis [29]. Lipogly-
cans were analyzed by SDS-PAGE (10 mg of proteins were loaded
on the gel for each strain) followed by periodic acid-silver nitrate
staining.
Lipoprotein quantification
Mycobacterial cells (1.5 g) were disrupted by sonication and
unbroken cells were removed by gentle centrifugation. Lipopro-
teins were extracted from the cleared lysate by a phenol/water
partition [6,7]. The phenol phase containing lipoproteins was
dialyzed against water, dried and weighed. No significant variation
could be observed between the different strains.
HEK-TLR2 experiments
HEK-Blue
TM-2 cells (Invivogen, Toulouse, France), derivatives
of HEK293 cells that stably express the human TLR2 and CD14
genes along with a NF-kB-inducible reporter system (secreted
alkaline phosphatase) were added in the HEK-Blue
TM Detection
medium (Invivogen), which contains a substrate for alkaline
phosphatase, at 5610
4 cells per well in 96-wells plates and
incubated with the different mycobacterial strains at MOI ranging
from 1 to 0.1. Alkaline phosphatase activity was measured after
18 hours by reading O.D. at 630 nm.
THP-1 experiments
THP-1-Blue
TM cells (Invivogen), derivatives of THP-1 mono-
cyte/macrophage human cells that stably express a NF-kB-
inducible reporter system (secreted alkaline phosphatase), were
added at 10
5 cells per well in 96-wells plates in HEK-Blue
TM
Detection medium (for NF-kB activation assay) or differentiated
with 20 ng/ml of PMA for 24 h in RPMI 1640 culture medium
(Lonza, Verviers, Belgium) (for IL-8 production assay). The
different mycobacterial strains were added at MOI ranging from
10 to 1 and, after 18 h, NF-kB activation was measured as
described above or cytokines were assayed in the supernatant by
sandwich ELISA using commercially available kits (Diaclone,
Besanc ¸on, France). To investigate TLR2 dependence, cells were
pre-incubated for 30 min at 37uC, before bacteria addition, with
5 mg/ml of anti-TLR2 antibodies (IgG1 clone T2.5, IgG2a clone
TL2.1 or IgA1, Invivogen) or isotype controls (IgG1, IgG2a,
eBioscience or IgA1, Invivogen). To determine bacilli uptake,
PMA-treated cells were infected for 1 h at 37uC with the various
M. smegmatis strains at MOI of 50, extensively washed, lysed and
plated onto agar for CFU counting.
Dendritic cell experiments
Monocytes were obtained from healthy blood donors (Etablisse-
ment Franc ¸ais du Sang, EFS, Toulouse). Written informed
consents were obtained from the donors under EFS contract
nu21/PVNT/TOU/IPBS01/2009–0052. Following articles
L1243-4 and R1243-61 of the French Public Health Code, the
contract was approved by the French Ministry of Science and
Technology (agreement nuAC 2009–921). Ethical approval was
not required in this case as only fluids in surplus were used in this
study, according to institutional guidelines.
Peripheral blood mononuclear cells were purified by Ficoll-
Paque centrifugation. Monocytes were purified by positive
selection using anti-CD14-coated magnetic microbeads (Miltenyi
Biotec). Sorted cells were .98% CD14+ as assessed by flow
cytometry staining. The recovered cells, referred to as monocytes,
were seeded in 6-well plates at 2610
6 cells/well in 1.5 ml DC-
medium described as RPMI 1640, 10% FCS (Lonza, Verviers,
Belgium) supplemented with 800 UI/ml GM-CSF and 500 UI/
ml IL-4 (Peprotech France). 0.5 ml fresh DC-medium was added
to culture at day 2. At day 5, cells were resuspended in fresh
medium and the different mycobacterial strains were added at a
MOI of 1. After 18 h, cytokines were assayed in the supernatant
by sandwich ELISA using commercially available kits (Diaclone,
Besanc ¸on, France). For monitoring CD40 and CD86 expression,
cells were harvested and resuspended in Dubelco’s PBS, 0.5%
BSA and labelled with CD40- or CD86-Phycoerythrin conjugated
antibody (Beckman Coulter). Cells were subjected to flow
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cytometer (FACSCalibur, Becton Dickinson).
Statistical analysis
Results are expressed as a mean 6 SD and were analyzed using
One-way analysis of variance followed by Tukey test to determine
significant differences between samples.
Results and Discussion
Construction of M. smegmatis strains with an increased
production of lipoglycans
Lipoglycans are biosynthesized via the sequential addition by
mannosyltransferases (ManTs) of mannosyl units on phosphatidyl-
myo-inositol, yielding phosphatidyl-myo-inositol mannosides (PIM)
and LM (Figure 1) [18]. LM can be further arabinosylated to give
lipoarabinomannan (LAM). ManTs involved in the first manno-
sylation steps use the soluble sugar nucleotide GDP-Mannose as
mannose donor whereas those catalyzing later steps require the
polyprenyl-phosphate based sugar donor, polyprenyl-monopho-
sphoryl-mannose. However the latter derives from GDP-Mannose,
which is thus the primary mannose donor in mycobacteria [30].
GDP-Mannose can be produced in three steps from either
exogenously acquired mannose or gluconeogenesis-derived fruc-
tose-6-phosphate. Mannose and fructose-6-phosphate are convert-
ed to mannose-6-phosphate by the action of a hexokinase and a
phosphomannose isomerase (PMI), respectively. Then mannose-6-
phosphate is transformed to mannose-1-phosphate by a phospho-
mannomutase (PMM) and finally to GDP-Mannose by a GDP-
Mannose pyrophosphorylase (GDPMP) (Figure 1). Rv3255c,
Rv3257c and Rv3264c have been shown to encode PMI [31],
PMM [32] and GDPMP [33] enzymes respectively and accord-
ingly have been renamed manA, manB and manC [32,34]. manA was
proved to be essential for mycobacterial growth in vitro in the
absence of an exogenous source of mannose [31]. High density
mutagenesis predicted manB and manC to be also essential in M.
tuberculosis [35]. In this context, we reasoned that boosting the
GDP-Mannose pathway in mycobacteria could result in a
subsequent increased production of lipoglycans. The proof of that
concept was demonstrated by McCarthy et al. [32] who showed
that M. smegmatis overexpressing M. tuberculosis manB gene
produced increased levels of PIM, LM and LAM. We thus PCR
amplified manA, manB, manC and pmmB gene copies from M.
tuberculosis H37Rv [36] and inserted them separately in the E. coli-
Mycobacterium shuttle vector pMV261. pmmB putative gene product
shows some homology with known PMMs [32,36]. The resulting
constructs, and the control plasmid carrying no insert gene, were
used to transform M. smegmatis mc
2155. We then assessed PMI,
PMM and GDPMP enzymatic activities in the different recom-
binant strains using in vitro assays on bacterial lysates. As expected,
overexpression of manA resulted in a more than 6-fold increase in
PMI activity as compared to the control strain whereas PMM and
GDPMP activities were not affected (Figure 2). Similarly, GDPMP
activity was augmented by around 2.5-fold in the manC
overexpressing strain (Msmeg/pMVmanC) but not in the other
ones (Figure 2). In the conditions used, no PMM activity could be
detected in the control or non-relevant strains. However, an
activity of around 0.6 mU/mg of total proteins was measured in
both strains overexpressing manB (Msmeg/pMVmanB)o rpmmB
(Msmeg/pMVpmmB) (Figure 2), indicating that PmmB is an
additional mycobacterial PMM. We thus had a set of recombinant
strains showing an individual increase of each enzymatic activity
involved in GDP-mannose biosynthesis. We then examined the
consequences in term of lipoglycan production. In a first
approach, we quantified in a lipoglycan-enriched fraction the
amount of the carbohydrates mannose and arabinose, known to
compose lipoglycans. An increase of around 1.7 fold of these
carbohydrates was observed for Msmeg/pMVmanB, Msmeg/
pMVpmmB and Msmeg/pMVmanC as compared to the control
strain (Msmeg/pMV) whereas no change was detected in Msmeg/
pMVmanA (Figure 3A). These results suggested an increase of
lipoglycan production in Msmeg/pMVmanB, Msmeg/pMVpmmB
and Msmeg/pMVmanC strains. We further analyzed lipoglycans by
SDS-PAGE followed by silver nitrate staining. They were loaded
on the gel according to a fixed amount of proteins. The gels
showed the presence of a higher amount of lipoglycans, with a
slight increase in the apparent molecular weight, in the same three
strains (Figure 3B). In contrast, we could not detect any significant
difference in the content of PIM among the various strains, as
revealed by thin-layer chromatography and MALDI mass
spectrometry analyses of the lipidic extracts (not shown). These
data indicate that the GDP-Mannose pool is in default amount for
LM and LAM biosynthesis in M. smegmatis, essentially as a result of
a limiting PMM activity.
Construction of a M. smegmatis strain with a reduced
production of lipoglycans
We have demonstrated above that pmmB gene product encodes
an enzyme with PMM activity and that the latter affects lipoglycan
biosynthesis (Figures 2, 3A and 3B). High density mutagenesis
previously proved that this gene was non-essential in M. tuberculosis
[35]. We thus investigated whether the deletion of its ortholog in
M. smegmatis (MSMEG_1695) could result in a strain producing
reduced amount of lipoglycans. We constructed a M. smegmatis
mutant by exchanging the wild-type allele of MSMEG_1695 with a
Km resistance cassette-disrupted allele. One clone, named Msmeg/
DpmmB, exhibiting an amplification pattern consistent with an
allelic exchange at the MSMEG_1695 locus, was retained for
further analyses. Carbohydrate quantification, as performed
Figure 1. GDP-Mannose biosynthesis pathway in mycobacteria.
Enzymatic steps considered in the present study are indicated with
plain line arrows. ManTs, mannosyltransferases; GDPMP, GDP-Mannose
pyrophosphorylase; PMI, phosphomannose isomerase; PMM, phospho-
mannomutase; PPM, polyprenyl-monophosphoryl-mannose.
doi:10.1371/journal.pone.0028476.g001
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DpmmB contained only half amount of arabinose and mannose as
compared to the wild-type strain (Figure 3C). SDS-PAGE analysis
confirmed that Msmeg/DpmmB produced reduced amount of LAM
and LM as compared to the wild-type strain (Figure 3D).
Lipoglycan production was restored in the mutant upon
complemention with pMV/MSMEG_1695 (Msmeg/DpmmB/CL).
Again the production of PIM was not affected in the mutant strain
(not shown).
Consequences of lipoglycan altered production on
mycobacteria-induced innate immune signaling
Three M. smegmatis recombinant strains moderately overpro-
ducing lipoglycans, Msmeg/pMVmanB, Msmeg/pMVpmmB and
Msmeg/pMVmanC, and a knock-out mutant with a reduced
production of lipoglycans, Msmeg/DpmmB, were thus available to
evaluate the possible implication of these compounds in myco-
bacteria sensing by innate immune receptors, including TLR2. It
is noteworthy that these strains contained wild-type amount of
lipoproteins (5563 mg per 1.5 g cells) as determined by analysis
and quantification of the phenol extracts. We first tested the
relative ability of the different strains to stimulate HEK293 cells
stably transfected with human TLR2 and CD14 genes (HEK-
TLR2 cells) and a NF-kB-inducible reporter system. All the strains
induced NF-kB activation in HEK-TLR2 cells (Figures 4A and
5A) but not in the parent HEK cells (Figure 4E and data not
shown), demonstrating that activation was specific for TLR2.
However, Msmeg/pMVmanB, Msmeg/pMVpmmB and Msmeg/
pMVmanC were reproducibly more stimulatory than the control
strains, Msmeg/pMV, and Msmeg/pMVmanA (Figure 4A), whereas
Figure 2. PMI, PMM and GDPMP enzymatic activities in the
M. smegmatis recombinant strains. Enzymatic activities were
determined on bacterial lysates using coupled assays [26,27,28]. The
results are presented as mU enzyme activity per mg protein of the
lysate and are mean 6 SD of three separate experiments using
independent bacterial cultures. ***, P,0.001.
doi:10.1371/journal.pone.0028476.g002
Figure 3. Altering the GDP-Mannose biosynthesis pathway impacts lipoglycan production. A, C) Arabinose and mannose quantification
in a lipoglycan-enriched fraction. These monosaccharides were quantified from an equivalent amount of 1 mg of proteins by capillary electrophoresis
after total acid hydrolysis [29]. The results are presented as nmol of the monosaccharide per mg protein in the fraction and are mean 6 SD of triplicate
assays from a representative experiment. Ara, arabinose; Man, mannose. **, P,0.01; ***, P,0.001; ns, not significant. In A), P value is given vs pMV. B,
D) Lipoglycan analysis by SDS-PAGE and silver nitrate staining. Lipoglycans were loaded on the gel on a protein basis. A representative gel is shown.
doi:10.1371/journal.pone.0028476.g003
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(Figure 5A), demonstrating an association between the level of
lipoglycan production on one hand and the magnitude of TLR2
signaling on the other hand. To confirm it in more physiological
cells, we investigated the relative capacity of the different strains to
activate the human THP-1 monocyte/macrophage cell line, using
a cell line derivative that stably expresses a NF-kB-inducible
reporter system. Again, we found that Msmeg/pMVmanB, Msmeg/
pMVpmmB and Msmeg/pMVmanC were more potent than the
control strains in their ability to induce NF-kB activation
(Figure 4B) and IL-8 (Figure 4C) and TNF-a (not shown) release.
THP-1 cells being strong producers of IL-8, this chemokine was
further used as readout of cell activation. Both NF-kB activation
(Figure 4F) and IL-8 production (Figure 4G) were found to depend
in part on TLR2 signaling, as determined by antibody blocking
experiments. Interestingly, Msmeg/DpmmB was less potent than the
wild-type strain in its ability to induce NF-kB activation (Figure 5B)
and IL-8 release (Figure 5C) in THP-1 cells. But this defect did not
impact on its uptake by these cells (Figure S2A). The different
recombinant strains were finally tested for their ability to induce
IL-8 production by and maturation of human monocyte-derived
dendritic cells (DCs). Msmeg/pMVmanB and Msmeg/pMVmanC
induced much more IL-8 than the control strains (Figure 4D) but
only a slightly higher expression of CD86 and CD40 maturation
markers (Figure S3). Msmeg/pMVpmmB stimulated IL-8
(Figure 4D) and CD86 and CD40 (Figure S3) to a level similar
to the control strains, but Msmeg/DpmmB mutant was found again
to be less stimulatory than the wild-type strain (Figure 5D).
Altogether the data demonstrate that lipoglycans are MAMPs
contributing to innate immune detection of M. smegmatis by
phagocytic cells, via TLR2 among other possible PRRs, as
revealed by NF-kB activation and IL-8 production.
Construction and characterization of M. smegmatis lspA
mutant
As far as TLR2 is concerned, lipoproteins/lipopeptides are
considered to be the strongest agonists of the receptor characterized
Figure 4. Lipoglycan increased production is associated with an enhancement of innate immune signaling. A, B, E, F) NF-kB activation
in HEK (A, E) and THP-1 (B, F) cells. C, D, G) IL-8 production by THP-1 (C, G) and human monocyte-derived dendritic (D) cells. Cells were incubated with
bacteria at MOI of 1. In F and G, cells were pre-incubated for 30 min at 37uC before bacteria addition with various antibodies, anti-TLR2 and isotype
controls, at a concentration of 5 mg/ml. The results are mean 6 SD of triplicate wells and are representative of at least three separate experiments
using independent bacterial cultures and different MOI. *, P,0.05; **, P,0.01; ***, P,0.001; ns, not significant. In A, B, C and D), P value is given vs
pMV. n.i., not induced.
doi:10.1371/journal.pone.0028476.g004
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lipoprotein processing (DlspA) was found to be impaired in its
capacity to stimulate TLR2 in reporter cells [22], strongly
suggesting that lipoproteins play a predominant role in mycobac-
teria sensing by TLR2 [37,38]. To investigate the relative
contribution of lipoproteins and lipoglycans in this process, we
constructed a deletion mutant of lspA in M. smegmatis by allelic
exchange, Msmeg/DlspA. lspA gene encodes prelipoprotein signal
peptidase whose absence results in lipoproteins with a larger
apparent molecular weight on SDS-PAGE, as a result of a non-
cleaved off signal peptide [22,39,40]. Since very few M. smegmatis
lipoproteins have been characterized so far and no antibody is
available, an unmarked lspA deletion mutant, Msmeg/DlspAres,w a s
transformed with a plasmid encoding the HA-tagged endogenous
lipoprotein Msmeg1712 [41]. As expected, immunoblotting
revealed that migration of Msmeg1712-HA was slower in Msmeg/
DlspAres than that in the wild-type (Figure 6A). A wild-type
migration was restored when the mutant strain was complemented
with the wild-type allele of lspA. In agreement with the results of
Banaiee et al. [22], Msmeg/DlspA showed a dramatically reduced
capacity, as compared to wild-type and complemented strains, to
induce NF-kB activation in HEK-TLR2 and THP-1 cells
(Figures 5E and F) and IL-8 production in THP-1 and DCs
(Figures 5G and H). Moreover, its uptake by THP-1 cells was
decreased (Figure S2B). DlspA mutant reproducibly showed a defect
stronger than that of DpmmB mutant (Figures 5E to H), further
suggesting that lipoproteins play a predominant role as TLR2
ligands on M. smegmatis cell surface. Indeed, DlspA mutant produces
non-mature lipoproteins, i.e. prolipoproteins, which remain seques-
tered to the cytosol and plasma membrane [40]and per se are devoid
of TLR2 stimulating activity [22]. However, lipoproteins (more
than 100 genes in M. tuberculosis genome [36]) have also
physiological functions in the bacillus, most of them remaining
unknown so far. Of note, one lipoprotein, lpqW, was recently
implicated in the regulation of lipoglycan biosynthesis [42]. In this
light, to determine whether prolipoprotein processing was required
for proper lipoglycan biosynthesis, the latter were purified from the
different strains and analyzed by SDS-PAGE. No quantitative
differences were observed (not shown). However, interestingly both
LAM and LM from DlspA mutant exhibited a lower apparent
molecular weight (Figure 6B). This was confirmed by MALDI-TOF
mass spectrometry analysis, which revealed molecular mass
decreased by around 2 kDa, as compared to that of wild-type and
complemented strains (Figure S4). Chemical analyses [29] indicated
that this decrease in size resulted from a smaller mannan domain
(not shown). So, these data indicate that lspA deletion in
mycobacteria leads to an alteration of biosynthesis pathways not
only of lipoproteins but also of the other family of TLR2 ligands,
lipoglycans. Finally, it has been recently found that M. tuberculosis
lipoprotein LprG is a glycolipid chaperone that increases the
apparent potency of purified lipoglycans to stimulate TLR2 [43].
So, the strongly reduced potency of mycobacteria DlspA mutants to
Figure 5. Lipoglycan reduced production is associated with a decrease of innate immune signaling. A, B, E, F) NF-kB activation in HEK-
TLR2 (A, E) and THP-1 (B, F) cells. C, D, G, H) IL-8 production by THP-1 (C, G) and human monocyte-derived dendritic (D, H) cells. Cells were incubated
with bacteria at MOI of 1. The results are mean 6 SD of triplicate wells and are representative of at least three separate experiments using
independent bacterial cultures and different MOI. *, P,0.05; **, P,0.01; ***, P,0.001. n.i., not induced.
doi:10.1371/journal.pone.0028476.g005
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stimulation by lipoprotein/lipopeptide agonists but rather by both
lipoproteins/lipopeptides and lipoglycans.
Conclusion
Innate immune detection of mycobacteria involves several
PRRs that cooperate to mediate both uptake of the bacilli into host
cells and activation of intracellular signaling cascades that signal
the presence of the bacterial invader [44]. Among these receptors,
TLR2 plays a key role in initiating the production of pro-
inflammatory cytokines and chemokines that are crucial to
eliciting the protective adaptative immune response [45]. We
demonstrate here a direct correlation between the amount of
lipoglycans in M. smegmatis cell envelope on one hand and the
magnitude of innate immune signaling in HEK-TLR2 reporter
cells, monocyte/macrophage THP-1 cell line and human dendritic
cells, as revealed by NF-kB activation and IL-8 production, on the
other hand. These data establish that lipoglycans are MAMPs
contributing to innate immune detection of mycobacteria, via
TLR2 among other PRRs. They also establish that ligands other
than lipopeptides/lipoproteins can be sensed at physiological
concentrations by TLR2. What are the precise cellular responses
specifically associated to lipoglycan recognition remain to be
investigated.
Supporting Information
Figure S1 List of primers used in this study.
(DOC)
Figure S2 M. smegmatis strains uptake by THP-1 cells.
Cells were infected for 1 h at 37uC with the various M. smegmatis
strains at MOI of 50, extensively washed, lysed and plated onto
agar for CFU counting. The results are expressed as the
percentage of the inoculum being associated to the cells and are
mean 6 SD of triplicate wells and are representative of separate
experiments using independent bacterial cultures and different
MOI. **, P,0.01; ns, not significant.
(TIF)
Figure S3 Expression of dendritic cell surface markers
CD86 (A, B) and CD40 (C, D). Cells were incubated overnight
with the various M. smegmatis strains at MOI of 1.
(TIF)
Figure S4 MALDI-TOF/MS analysis of LAM. 0.5 mlo fM.
smegmatis wild-type (A), DlspA (B) and DlspA/CL (C) LAM solutions
at 10 mg/ml were mixed with 0.5 ml of the matrix solution (10 mg/
ml of 2,5-dihydroxybenzoic acid in ethanol/water, 1:1, v/v) and
analyzed by MALDI-TOF in the negative mode [29].
(TIF)
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